Biophys. Acta (BBA) Rev. Cancer 2018 ,1869 , 149–160. [CrossRef] 20. Gao, Q.; Liang, W.-W.; Foltz, S.M.; Mutharasu, G.; Jayasinghe, R.G.; Cao, S.; Liao, W.-W.; Reynolds, S.M.; Wyczalkowski, M.A.; Yao, L.; et al. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Cell Rep. 2018 ,23, 227–238.e3. [CrossRef] 21. Samstein, R.M.; Lee, C.-H.; Shoushtari, A.N.; Hellmann, M.D.; Shen, R.; Janjigian, Y.Y.; Barron, D.A.; Zehir, A.; Jordan, E.J.; Omuro, A.; et al. Tumor Mutational Load Predicts Survival after Immunotherapy across Multiple Cancer Types. Nat. Genet. 2019 ,51, 202–206. [CrossRef] 22. Starck, S.R.; Shastri, N. Nowhere to Hide: Unconventional Translation Yields Cryptic Peptides for Immune Surveillance. Immunol. Rev. 2016 ,272, 8–16. [CrossRef] 23. Wright, B.W.; Yi, Z.; Weissman, J.S.; Chen, J. The Dark Proteome: Translation from Noncanonical Open Reading Frames. Trends Cell Biol. 2022 ,32, 243–258. [CrossRef] 24. Cuevas, M.V .R.; Hardy, M.-P .; Holl ý, J.; Bonneil, É.; Durette, C.; Courcelles, M.; Lanoix, J.; C ôté, C.; Staudt, L.M.; Lemieux, S.; et al. Most Non-Canonical Proteins Uniquely Populate the Proteome or Immunopeptidome. Cell Rep. 2021 ,34, 108815. [CrossRef] 25. Ouspenskaia, T.; Law, T.; Clauser, K.R.; Klaeger, S.; Sarkizova, S.; Aguet, F.; Li, B.; Christian, E.; Knisbacher, B.A.; Le, P .M.; et al. Unannotated Proteins Expand the MHC-I-Restricted Immunopeptidome in Cancer. Nat.